Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 180

Results For "Development"

2929 News Found

China medical devices market to surpass $42 billion in 2022: GlobalData
News | July 10, 2022

China medical devices market to surpass $42 billion in 2022: GlobalData

Domestic devices are usually preferred over imported medical devices in the national or regional procurement.


WuXi XDC and AbTis sign MoU for manufacturing of antibody drug conjugates
Biotech | July 10, 2022

WuXi XDC and AbTis sign MoU for manufacturing of antibody drug conjugates

AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing


We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
interviews | July 08, 2022

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing


ALPLA acquires Polish packaging manufacturer APON
News | July 08, 2022

ALPLA acquires Polish packaging manufacturer APON

The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019


Evonik launches non-animal-derived collagen platform for medical device applications
News | July 08, 2022

Evonik launches non-animal-derived collagen platform for medical device applications

Fermentation-based manufacturing leverages Evonik’s biotechnology platform


Lupin’s Somerset manufacturing plant Receives EIR from US FDA
Drug Approval | July 08, 2022

Lupin’s Somerset manufacturing plant Receives EIR from US FDA

The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated


WuXi STA opens Oligonucleotide and Peptide manufacturing facility
News | July 08, 2022

WuXi STA opens Oligonucleotide and Peptide manufacturing facility

Site Enhances New Modality CRDMO Platform Capacity for Customers


Lonza to build large-scale fill & finish facility in Switzerland
News | July 07, 2022

Lonza to build large-scale fill & finish facility in Switzerland

The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026


Regeneron completes purchase of Sanofi's stake in Libtayo
News | July 06, 2022

Regeneron completes purchase of Sanofi's stake in Libtayo

Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions